AIM ImmunoTech Inc.
AIM- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000946644
In the last 90 days, AIM ImmunoTech Inc. insiders filed 4 open-market purchases and 0 sales; 18 institutions reported holding it in 13F filings for Q2 2026, worth $325.6K in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding AIM ImmunoTech Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 35 | 34 | −1 |
| Shares | 4.65M | 4.83M | +183.7K (+4.0%) |
| Value | $919.3K | $590.0K | −$329.3K (−35.8%) |
New holders (5)
Institutions that held AIM ImmunoTech Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Crescent Grove Advisors, LLC | 45,390 | $5.55K | 0.00% |
| J.W. Cole Advisors, Inc. | 15,000 | $1.83K | 0.00% |
| Harbour Investments, Inc. | 1,000 | $122 | 0.00% |
| Steward Partners Investment Advisory, LLC | 220 | $27 | 0.00% |
| Royal Bank of Canada | 550 | $0 | 0.00% |
Sold out (6)
Institutions that held AIM ImmunoTech Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Susquehanna International Group, LLP | 38,040 | $7.53K |
| Virtu Financial LLC | 36,658 | $7.00K |
| HRT Financial LP | 31,648 | $6.00K |
| Baader Bank INC | 13,389 | $2.37K |
| CI Private Wealth, LLC | 10,100 | $2.00K |
| Citigroup Inc | 864 | $171 |